GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » EV-to-Revenue

JD Health International (HKSE:06618) EV-to-Revenue : 0.72 (As of May. 02, 2024)


View and export this data going back to 2020. Start your Free Trial

What is JD Health International EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, JD Health International's enterprise value is HK$42,279 Mil. JD Health International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$58,550 Mil. Therefore, JD Health International's EV-to-Revenue for today is 0.72.

The historical rank and industry rank for JD Health International's EV-to-Revenue or its related term are showing as below:

HKSE:06618' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.47   Med: 3.07   Max: 42.26
Current: 0.72

During the past 7 years, the highest EV-to-Revenue of JD Health International was 42.26. The lowest was 0.47. And the median was 3.07.

HKSE:06618's EV-to-Revenue is ranked better than
75.98% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.84 vs HKSE:06618: 0.72

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-02), JD Health International's stock price is HK$30.05. JD Health International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$18.51. Therefore, JD Health International's PS Ratio for today is 1.62.


JD Health International EV-to-Revenue Historical Data

The historical data trend for JD Health International's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International EV-to-Revenue Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 18.58 3.89 3.33 1.36

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.89 - 3.33 - 1.36

Competitive Comparison of JD Health International's EV-to-Revenue

For the Medical Care Facilities subindustry, JD Health International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JD Health International's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where JD Health International's EV-to-Revenue falls into.



JD Health International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

JD Health International's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=42279.443/58549.964
=0.72

JD Health International's current Enterprise Value is HK$42,279 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JD Health International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$58,550 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JD Health International  (HKSE:06618) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

JD Health International's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=30.05/18.505
=1.62

JD Health International's share price for today is HK$30.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$18.51.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JD Health International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of JD Health International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


JD Health International (HKSE:06618) Business Description

Traded in Other Exchanges
Address
No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines